US Pharma MarketingSupernus and Indivior merge to create scaled, CNS-focused entity
Through this merger, Supernus and Indivior will combine their commercial medicinal portfolios, which span CNS and opioid use disorders (OUDs).
Through this merger, Supernus and Indivior will combine their commercial medicinal portfolios, which span CNS and opioid use disorders (OUDs).
Source: Pharmaceutical Technology